Chemoinformaics analysis of 2-BENZOXAZOLINONE
| Molecular Weight | 135.122 | nRot | 0 |
| Heavy Atom Molecular Weight | 130.082 | nRig | 11 |
| Exact Molecular Weight | 135.032 | nRing | 2 |
| Solubility: LogS | -1.841 | nHRing | 1 |
| Solubility: LogP | 1.203 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 17.728 |
| nHD | 1 | BPOL | 8.19003 |
| QED | 0.588 |
| Synth | 2.021 |
| Natural Product Likeliness | -0.471 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.064 |
| HIA | 0.007 |
| CACO-2 | -4.726 |
| MDCK | 0.00003 |
| BBB | 0.219 |
| PPB | 0.551199 |
| VDSS | 0.542 |
| FU | 0.295966 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.914 |
| CYP2c19-inh | 0.334 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.044 |
| CYP2d6-inh | 0.098 |
| CYP2d6-sub | 0.092 |
| CYP3a4-inh | 0.024 |
| CYP3a4-sub | 0.239 |
| CL | 8.538 |
| T12 | 0.866 |
| hERG | 0.01 |
| Ames | 0.015 |
| ROA | 0.064 |
| SkinSen | 0.433 |
| Carcinogencity | 0.815 |
| EI | 0.981 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.704435 |